Skip to content
sellWeak cluster of 410b5-1 plan

Adam H Schechter sold $1.5M of LH

President & CEO at LABCORP HOLDINGS INC.. 6,121 shares at an average of $244.62, traded Feb 11, 2025, filed Feb 13, 2025.

Warning score
30
Value
$1.5M
6,121 shares
Holdings after
86,445
-7% from before
From 52-week low
+16%
low $207.55, close $240.66
From 52-week high
-3%
high $246.95, as of Feb 11, 2025

Score components

  • Role
    CEO
    +25
  • Trade size
    $1.5M at market
    +25
  • Share of holdings sold
    Sold 6.6% of holdings
    0
  • Cluster
    4 insiders selling within 14 days
    +15
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

LHOct 9, 2026 · close 312.15
Since filing Feb 13, 2025: +29.8%SPY +30.2% · excess -0.4%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001127602-25-004543, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Feb 11, 2025SOpen-market sale
Common Stock10b5-1
-6,121$244.62$1.5M86,445Feb 13, 2025
Feb 11, 2025MOption exercise
Common Stock10b5-1
+2,963--89,408Feb 13, 2025
Feb 11, 2025FTax withholding
Common Stock10b5-1
-1,226$245.14$301k88,182Feb 13, 2025
Feb 11, 2025AGrant or award
Non-qualified Stock Optionsderivative10b5-1
+33,100$0.00$033,100Feb 13, 2025
Feb 11, 2025AGrant or award
Restricted Stock Unitderivative10b5-1
+10,970$0.00$026,102Feb 13, 2025
Feb 11, 2025MOption exercise
Restricted Stock Unitderivative10b5-1
-2,963$0.00$023,139Feb 13, 2025

Related signals

Other insiders at LABCORP HOLDINGS INC. and this insider’s other filings.

ScoreSideCompanyInsiderValueSharesFiled
38Weaksell 210b5-1LH
LABCORP HOLDINGS INC.
Mark S Schroeder
EVP, Pres Diagnostics & COO
$610k2,635
20Weaksell 210b5-1LH
LABCORP HOLDINGS INC.
Amy B. Summy
EVP, Chief Marketing Officer
$176k758
41Moderatesell 4LH
LABCORP HOLDINGS INC.
Kerrii B Anderson
director
$128k500
45Moderatesell 510b5-1LH
LABCORP HOLDINGS INC.
Mark S Schroeder
EVP, Pres Diagnostics & COO
$1.3M5,339
55Moderatesell 6LH
LABCORP HOLDINGS INC.
Sandra D van der Vaart
EVP, Chief Legal Officer
$330k1,314
17Weaksell 610b5-1LH
LABCORP HOLDINGS INC.
Amy B. Summy
EVP, Chief Marketing Officer
$57k226
40Moderatesell 5LH
LABCORP HOLDINGS INC.
Peter J Wilkinson
SVP, Chief Accounting Officer
$348k1,413
8Weaksell10b5-1LH
LABCORP HOLDINGS INC.
Kerrii B Anderson
director
$235k1,000
50Moderatesell 4LH
LABCORP HOLDINGS INC.
Glenn A Eisenberg
Executive Vice President
$2.8M11,711
48Moderatesell 4LH
LABCORP HOLDINGS INC.
Dwight Gary Gilliland
director
$241k1,000

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Adam H Schechter sold $1.5M of LH | InsiderTell